2023-25989. Importer of Controlled Substances Application: VHG Labs DBA LGC Standards  

  • Start Preamble

    AGENCY:

    Drug Enforcement Administration, Justice.

    ACTION:

    Notice of application.

    SUMMARY:

    VHG Labs DBA LGC Standards has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

    DATES:

    Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before December 26, 2023. Such persons may also file a written request for a hearing on the application on or before December 26, 2023.

    ADDRESSES:

    The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152.

    End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In accordance with 21 CFR 1301.34(a), this is notice that on November 6, 2023, VHG Labs DBA LGC Standards, 3 Perimeter Road, Manchester, New Hampshire 03103–3341, applied to be registered as an importer of the following basic class(es) of controlled substance(s):

    Controlled substanceDrug codeSchedule
    Amineptine (7-[(10,11-dihydro-5Hdibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid)1219I
    Mesocarb (N-phenyl-N′-(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate)1227I
    3-Fluoro-N-methylcathinone (3-FMC)1233I
    4-Fluoro-N-methylcathinone (4-FMC) 1238 I N1238I
    Pentedrone (α-methylaminovalerophenone)1246I
    4-Methyl-N-ethylcathinone (4-MEC)1249I
    Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2-amine) 1478 I N1478I
    N,N-Dimethylamphetamine1480I
    Fenethylline1503I
    4-Methylaminorex (cis isomer)1590I
    4,4′-Dimethylaminorex (4,4′-DMAR; 4,5-dihydro-4-1595 I N methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine)1595I
    Mecloqualone2572I
    ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide)7010I
    5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone7011I
    AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide)7012I
    JWH-019 (1-Hexyl-3-(1-naphthoyl)indole)7019I
    FUB-AMB, MMB-FUBINACA, AMB-FUBINACA (2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3-methylbutanoate)7021I
    AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide)7023I
    THJ-2201 ([1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone)7024I
    5F-AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluropentyl)-1H-indazole-3-carboximide)7025I
    AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide)7031I
    5F-ADB, 5F-MDMB-PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate)7034I
    5F-MDMB-PICA (methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate)7041I
    MDMB-CHMICA, MMB-CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate)7042I
    5F-APINACA, 5F-AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide)7049I
    Start Printed Page 82402
    4-CN-CUML-BUTINACA, 4-cyano-CUMYL-BUTINACA, 4-CN-CUMYL BINACA, CUMYL-4CN-BINACA, SGT-78 (1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide)7089I
    JWH-073 (1-Butyl-3-(1-naphthoyl)indole)7173I
    JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole)7200I
    AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole)7201I
    PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate)7222I
    5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate)7225I
    N-ethylhexedrone 7246 I N7246I
    Alpha-ethyltryptamine7249I
    2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (methoxetamine)7286I
    CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol)7297I
    2C-T-7 (2,5-Dimethoxy-4-(n)-propylthiophenethylamine7348I
    2C-T-2 (2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine)7385I
    3,4,5-Trimethoxyamphetamine7390I
    4-Bromo-2,5-dimethoxyamphetamine7391I
    4-Bromo-2,5-dimethoxyphenethylamine7392I
    4-Methyl-2,5-dimethoxyamphetamine7395I
    2,5-Dimethoxy-4-ethylamphetamine7399I
    3,4-Methylenedioxyamphetamine7400I
    3,4-Methylenedioxy-N-ethylamphetamine7404I
    Alpha-methyltryptamine7432I
    Diethyltryptamine7434I
    Dimethyltryptamine7435I
    5-Methoxy-N,N-diisopropyltryptamine7439I
    N-Ethyl-1-phenylcyclohexylamine7455I
    1-(1-Phenylcyclohexyl)pyrrolidine7458I
    1-[1-(2-Thienyl)cyclohexyl]piperidine7470I
    N-Benzylpiperazine7493I
    2C-D (2-(2,5-Dimethoxy-4-methylphenyl) ethanamine)7508I
    2C-E (2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine)7509I
    2C-I 2-(4-iodo-2,5-dimethoxyphenyl) ethanamine)7518I
    2C-C 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine)7519I
    2C-N (2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine)7521I
    2C-P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine)7524I
    2C-T-4 (2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine)7532I
    25B-NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine)7536I
    25C-NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine)7537I
    25I-NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine)7538I
    N-Ethypentylone, ephylone (1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one)7543I
    alpha-pyrrolidinopentiophenone (α-PVP)7545I
    alpha-pyrrolidinobutiophenone (α-PBP)7546I
    Ethylone7547I
    AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole)7694I
    Difenoxin9168I
    Nicomorphine9312I
    Drotebanol9335I
    U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide)9547I
    AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide))9551I
    MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine))9560I
    Acetylmethadol9601I
    Alphameprodine9604I
    Benzethidine9606I
    Betameprodine9608I
    Clonitazene9612I
    Dextromoramide9613I
    Isotonotazene (N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine)9614I
    Dimenoxadol9617I
    Dimepheptanol9618I
    Dimethylthiambutene9619I
    Dioxaphetyl butyrate9621I
    Dipipanone9622I
    Etonitazene9624I
    Ketobemidone9628I
    Levomoramide9629I
    Noracymethadol9633I
    Normethadone9635I
    Piritramide9642I
    Racemoramide9645I
    1-Methyl-4-phenyl-4-propionoxypiperidine9661I
    Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1Hbenzimidazol-1-yl)ethan-1-amine9757I
    Protonitazene (N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine)9759I
    Para-Fluorofentanyl9812I
    3-Methylfentanyl9813I
    4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide)9824I
    Start Printed Page 82403
    Beta-hydroxyfentanyl9830I
    Beta-hydroxy-3-methylfentanyl9831I
    3-Methylthiofentanyl9833I
    Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide)9834I
    Thiofentanyl9835I
    Beta-hydroxythiofentanyl9836I
    Ocfentanil9838I
    beta′-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide; also known as β′-phenyl fentanyl; 3-phenylpropanoyl fentanyl)9842I
    N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide9843I
    Crotonyl fentanyl ((E-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide)9844I
    Cyclopropyl Fentanyl9845I
    ortho-Fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide; also known as 2-fluorobutyryl fentanyl)9846I
    Nabilone7379II
    Alphaprodine9010II
    Levomethorphan9210II
    Racemethorphan9732II
    Alfentanil9737II

    The company plans to import the listed controlled substances for distribution for analytical testing purposes. No other activities for these drug codes are authorized for this registration.

    Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or non-approved finished dosage forms for commercial sale.

    Start Signature

    Claude Redd,

    Acting Deputy Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2023-25989 Filed 11-22-23; 8:45 am]

    BILLING CODE P

Document Information

Published:
11/24/2023
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice of application.
Document Number:
2023-25989
Dates:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before December 26, 2023. Such persons may also file a written request for a hearing on the application on or before December 26, 2023.
Pages:
82401-82403 (3 pages)
Docket Numbers:
Docket No. DEA-1294
PDF File:
2023-25989.pdf